137 related articles for article (PubMed ID: 36939390)
21. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
[TBL] [Abstract][Full Text] [Related]
22. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
[TBL] [Abstract][Full Text] [Related]
23. Optimization of therapeutic strategy for p16-positive oropharyngeal squamous cell carcinoma: Multi-institutional observational study based on the national Head and Neck Cancer Registry of Japan.
Saito Y; Hayashi R; Iida Y; Mizumachi T; Fujii T; Matsumoto F; Beppu T; Yoshida M; Shinomiya H; Kamiyama R; Kitano M; Yokoshima K; Fujimoto Y; Hama T; Yamashita T; Okami K; Miura K; Fujisawa T; Sano D; Kato H; Minami S; Sugasawa M; Masuda M; Ota I; Iwae S; Kawata R; Monden N; Imai T; Asakage T; Okada M; Yoshikawa T; Tanioka K; Kitayama M; Doi M; Fujii S; Fujii M; Oridate N; Nakamizo M; Yoshimoto S; Homma A; Nibu KI; Yane K
Cancer; 2020 Sep; 126(18):4177-4187. PubMed ID: 32648953
[TBL] [Abstract][Full Text] [Related]
24. Immunotherapy in HPV-Related Oropharyngeal Cancers.
Roof L; Yilmaz E
Curr Treat Options Oncol; 2023 Mar; 24(3):170-183. PubMed ID: 36719604
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma: The ORATOR2 Phase 2 Randomized Clinical Trial.
Palma DA; Prisman E; Berthelet E; Tran E; Hamilton S; Wu J; Eskander A; Higgins K; Karam I; Poon I; Husain Z; Enepekides D; Hier M; Sultanem K; Richardson K; Mlynarek A; Johnson-Obaseki S; Odell M; Bayley A; Dowthwaite S; Jackson JE; Dzienis M; O'Neil J; Chandarana S; Banerjee R; Hart R; Chung J; Tenenholtz T; Krishnan S; Le H; Yoo J; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Chen J; Parker C; Wehrli B; Kwan K; Theurer J; Sathya J; Hammond JA; Read N; Venkatesan V; MacNeil SD; Fung K; Nichols AC
JAMA Oncol; 2022 Jun; 8(6):1-7. PubMed ID: 35482348
[TBL] [Abstract][Full Text] [Related]
26. Concurrent Cetuximab-based bioradiotherapy versus Cisplatin-based Chemoradiotherapy in the Definitive Management of Favourable Biology Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma: Systematic Review and Meta-analysis.
Swain M; Kannan S; Srinivasan S; Agarwal JP; Gupta T
Clin Oncol (R Coll Radiol); 2022 Dec; 34(12):786-795. PubMed ID: 35387752
[TBL] [Abstract][Full Text] [Related]
27. Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.
Huo Z; Fu S; Ma C; Sheng S
BMC Cancer; 2022 May; 22(1):535. PubMed ID: 35549914
[TBL] [Abstract][Full Text] [Related]
28. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
[TBL] [Abstract][Full Text] [Related]
29. Impact of Race and Insurance Status on Primary Treatment for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Habib AM; Carey RM; Prasad A; Mady LJ; Shinn JR; Bur AM; Brody RM; Cannady SB; Rajasekaran K; Ibrahim SA; Newman JG; Brant JA
Otolaryngol Head Neck Surg; 2022 Jun; 166(6):1062-1069. PubMed ID: 34253112
[TBL] [Abstract][Full Text] [Related]
30. Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) - A Trans-Tasman Radiation Oncology Group Study.
Rischin D; King M; Kenny L; Porceddu S; Wratten C; Macann A; Jackson JE; Bressel M; Herschtal A; Fisher R; Fua T; Lin C; Liu C; Hughes BGM; McGrath M; McDowell L; Corry J
Int J Radiat Oncol Biol Phys; 2021 Nov; 111(4):876-886. PubMed ID: 34098030
[TBL] [Abstract][Full Text] [Related]
31. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
32. The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.
Skillington SA; Kallogjeri D; Lewis JS; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):253-259. PubMed ID: 27918781
[TBL] [Abstract][Full Text] [Related]
33. Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Routman DM; Kumar S; Chera BS; Jethwa KR; Van Abel KM; Frechette K; DeWees T; Golafshar M; Garcia JJ; Price DL; Kasperbauer JL; Patel SH; Neben-Wittich MA; Laack NL; Chintakuntlawar AV; Price KA; Liu MC; Foote RL; Moore EJ; Gupta GP; Ma DJ
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):530-538. PubMed ID: 35157995
[TBL] [Abstract][Full Text] [Related]
34. Presentation and outcomes of patients with clinically T1-2, N0 oropharynx squamous cell carcinoma: The interplay of primary treatment modality and human papillomavirus status.
Al-Qurayshi Z; Zhu VL; Bayon R; Buchakjian MR
Head Neck; 2023 Jan; 45(1):64-74. PubMed ID: 36205359
[TBL] [Abstract][Full Text] [Related]
35. Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy.
Lu JS; Cao AC; Shimunov D; Sun L; Lukens JN; Lin A; Cohen RB; Basu D; Cannady SB; Rajasekaran K; Weinstein GS; Brody RM
Laryngoscope; 2023 Nov; 133(11):3013-3020. PubMed ID: 37129315
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Patients With Single-Node Metastasis of Human Papillomavirus-Related Oropharyngeal Cancer Treated With Transoral Surgery.
Chen SY; Sinha P; Last A; Ettyreddy A; Kallogjeri D; Pipkorn P; Rich JT; Zevallos JP; Paniello R; Puram SV; Van Abel K; Moore EJ; Oppelt P; Palka K; Adkins D; Daly M; Gay H; Thorstad WL; Jackson RS
JAMA Otolaryngol Head Neck Surg; 2021 Jan; 147(1):16-22. PubMed ID: 33151273
[TBL] [Abstract][Full Text] [Related]
37. Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancer.
Aden AA; Olawuni FO; Abdel-Halim CN; Zhu AQ; Haller TJ; O'Byrne TJ; Moore EJ; Price DL; Tasche KL; Ma DJ; Lester SC; Gamez M; Neben-Wittich MA; Price K; Fuentes-Bayne HE; Routman D; Van Abel KM
Oral Oncol; 2024 Feb; 149():106675. PubMed ID: 38211528
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
Dalianis T
Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
40. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
